Utah Medical Products, Inc. Reports Corrected Results of Tender Offer
ACCESSWIRE•29/10/2026•12:10 ET
0
Key Highlights
- ➤327,740 shares purchased at $75.00 each in expired tender offer
- ➤$24,580,500 spent repurchasing Utah Medical Products shares
- ➤2,849,041 UTMD shares remained outstanding after the tender offer
- ➤$107,720 depositary and information-agent fees plus $6,732 SEC filing fees
- ➤75.35/share effective tender-offer cost, excluding 1% federal excise tax
SALT LAKE CITY, UT / ACCESS Newswire / October 29, 2026 / On September 24, Utah Medical Products, Inc. (Nasdaq:UTMD) offered to purchase up to 650,000 shares of its common stock at $75.00 per share. The issuer Tender Offer expired Tuesday October 27.
In short, 327,740 shares were purchased for $24,580,500. Remaining UTMD shares outstanding at this date are 2,849,041 including 1,775 employee option shares exercised in October.
Get started
Create a free account to read the full story.